Biocept Enters into $10M Credit Facility | GenomeWeb

NEW YORK (GenomeWeb) – Biocept has entered into a $10 million loan and security agreement with Oxford Finance, the San Diego-based oncology diagnostics firm said in a US Securities and Exchange document on Tuesday.

Biocept received a $5 million loan on April 30 and will receive another $5 million loan prior to Dec. 31, 2015, subject to the firm achieving at least $9 million in product and service revenues for a six-month period ending no later than Nov. 30, 2015.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.